SCHEMBL2330262

SCHEMBL2330262

CCC[C@@H](CN[C@@H](CC)C(=O)OC)CC(=O)OCC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 1/20 0.36
GAA P10253 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
ALDH1A1 P00352 5/20 0.33
KMT2A Q03164 2/20 0.33
CYP3A4 P08684 2/20 0.33
ALOX15 P16050 2/20 0.33
TSHR P16473 2/20 0.33
POLB P06746 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
FAAH O00519 1/20 0.33
CYP2D6 P10635 1/20 0.33
CHRM1 P11229 1/20 0.33
ADORA1 P30542 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TAS1R3 Q7RTX0 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2330264 1.00 MGAM (0.36) MGAMGAASIMGAM2CA1
SCHEMBL2330257 0.91 CA1 (0.38) CA1CA2CYP3A4TSHRPOLB
SCHEMBL2330255 0.91 CA1 (0.38) CA1CA2CYP3A4TSHRPOLB
SCHEMBL2331090 0.88 MGAM (0.36) MGAMGAASIMGAM2L3MBTL1
SCHEMBL2331088 0.88 MGAM (0.36) MGAMGAASIMGAM2L3MBTL1
SCHEMBL562792 0.87 MGAM (0.35) MGAMGAASIMGAM2CA1
SCHEMBL2322660 0.87 MGAM (0.35) MGAMGAASIMGAM2CA1
Hydrochloric Acid SCHEMBL6226702 0.86 MGAM (0.34) MGAMGAASIMGAM2L3MBTL1
SCHEMBL2326252 0.85 CA1 (0.38) CA1CA2KMT2APOLBTAS1R3
SCHEMBL2326246 0.85 CA1 (0.38) CA1CA2KMT2APOLBTAS1R3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8338621-B2 Process for the preparation of 2-oxo-1-pyrrolidine derivatives UCB S.A. (BE) 2012-12-25 US disclosed
EP-1806339-B1 Process for the preparation of 2-oxo-1-pyrrolidine derivatives UCB PHARMA SA (BE) 2011-08-17 EP disclosed
US-20080009638-A1 PROCESS FOR THE PREPARATION OF 2-OXO-1-PYRROLIDINE DERIVATIVES UCB S.A. (BE) 2008-01-10 US disclosed
EP-1806339-A1 Process for the preparation of 2-oxo-1-pyrrolidine derivatives UCB, S.A. (BE) 2007-07-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080009638-A1 PROCESS FOR THE PREPARATION OF 2-OXO-1-PYRROLIDINE DERIVATIVES CYP2F1, CYP3A5, SULT1E1 MGAM 597/4885GAA 1106/4885SI 252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.